Cibc Asset Management Inc Astrazeneca PLC Transaction History
Cibc Asset Management Inc
- $31.2 Billion
- Q3 2025
A detailed history of Cibc Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Cibc Asset Management Inc holds 244,724 shares of AZN stock, worth $21.9 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
244,724
Previous 238,089
2.79%
Holding current value
$21.9 Million
Previous $16.6 Million
12.85%
% of portfolio
0.06%
Previous 0.06%
Shares
28 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...